6-chloro-3-[1-[[5-(4-fluorophenyl)oxolan-3-yl]methyl]piperidin-4-yl]-1H-benzimidazole-2-thione
C23H25ClFN3OS — CID 13151519
Data last refreshed: (MolForge compound catalog, from PubChem)
About 6-chloro-3-[1-[[5-(4-fluorophenyl)oxolan-3-yl]methyl]piperidin-4-yl]-1H-benzimidazole-2-thione
6-chloro-3-[1-[[5-(4-fluorophenyl)oxolan-3-yl]methyl]piperidin-4-yl]-1H-benzimidazole-2-thione (PubChem CID 13151519) has the molecular formula C23H25ClFN3OS and a molecular weight of 445.99 g/mol. Its IUPAC name is 6-chloro-3-[1-[[5-(4-fluorophenyl)oxolan-3-yl]methyl]piperidin-4-yl]-1H-benzimidazole-2-thione.
Molecular Properties
| Compound Name | 6-chloro-3-[1-[[5-(4-fluorophenyl)oxolan-3-yl]methyl]piperidin-4-yl]-1H-benzimidazole-2-thione |
|---|---|
| PubChem CID | 13151519 |
| Molecular Formula | C23H25ClFN3OS |
| Molecular Weight | 445.99 g/mol |
| Exact Mass | 445.14 |
| IUPAC Name | 6-chloro-3-[1-[[5-(4-fluorophenyl)oxolan-3-yl]methyl]piperidin-4-yl]-1H-benzimidazole-2-thione |
| SMILES | Fc1ccc(C2CC(CN3CCC(n4c(=S)[nH]c5cc(Cl)ccc54)CC3)CO2)cc1 |
| InChI | InChI=1S/C23H25ClFN3OS/c24-17-3-6-21-20(12-17)26-23(30)28(21)19-7-9-27(10-8-19)13-15-11-22(29-14-15)16-1-4-18(25)5-2-16/h1-6,12,15,19,22H,7-11,13-14H2,(H,26,30) |
| InChIKey | NCQXZIDEFYFXLG-UHFFFAOYSA-N |
| XLogP | 5.91 |
| TPSA | 33.19 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 30 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 445.99 |
| LogP ≤ 5 | 5.91 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 4 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Thiocarbonyl_group', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 13151519 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.